Potential for efficacy of the oncolytic herpes simplex virus 1716 in patients with oral squamous cell carcinoma.
Head and Neck.
Times cited: 41
A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer.
Clinical Cancer Research.
Times cited: 362